All Stories

  1. Clinical considerations on monkeypox antiviral medications: An overview

    Article • Pharmacology Research & Perspectives, December 2023, Wiley

    Dr Taher Entezari-Maleki

  2. Correction to: Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial

    Article • European Journal of Clinical Pharmacology, December 2023, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  3. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction: a randomized, double-blinded, three-arm parallel-group, controlled trial

    Article • European Journal of Clinical Pharmacology, October 2023, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  4. Global Variations in Heart Failure

    Article • JAMA, September 2023, American Medical Association (AMA)

    Dr Taher Entezari-Maleki

  5. Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance: A Randomized Clinical Trial

    Article • The Journal of Clinical Pharmacology, August 2023, Wiley

    Dr Taher Entezari-Maleki

  6. Review of Prediabetes

    Article • JAMA, August 2023, American Medical Association (AMA)

    Dr Taher Entezari-Maleki

  7. SGLT2 Inhibitors’ Cardiovascular Benefits in Individuals Without Diabetes, Heart Failure, and/or Chronic Kidney Disease: A Systematic Review

    Article • The Journal of Clinical Pharmacology, August 2023, Wiley

    Dr Taher Entezari-Maleki

  8. Effect of Caffeine Consumption on Cardiovascular Disease: An Updated Review

    Article • Pharmaceutical Medicine, March 2023, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  9. Effects of Allopurinol in the Prevention of Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial

    Article • Pharmaceutical Sciences, February 2023, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  10. Current evidence of COVID-19 vaccination-related cardiovascular events

    Article • Postgraduate Medicine, January 2023, Taylor & Francis

    Dr Taher Entezari-Maleki

  11. Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’

    Article • International Journal of Surgery, January 2023, Wolters Kluwer Health

    Dr Taher Entezari-Maleki

  12. Enoxaparin’s potential mechanisms against SARS-CoV-2

    Article • International Journal of Surgery, January 2023, Wolters Kluwer Health

    Dr Taher Entezari-Maleki

  13. Monkeypox treatment: Current evidence and future perspectives

    Article • Journal of Medical Virology, November 2022, Wiley

    Dr Taher Entezari-Maleki

  14. A commentary on “Unexpected sudden rise of human monkeypox cases in multiple non-endemic countries amid COVID-19 pandemic and salient counteracting strategies: Another potential global threat?” (Int J Surg 2022;103:106705)

    Article • International Journal of Surgery, October 2022, Wolters Kluwer Health

    Dr Taher Entezari-Maleki

  15. Synthesis, characterization, and the investigation of the applicability of citric acid functionalized Fe2O3 nanoparticles for the extraction of carvedilol from human plasma using DFT calculations and clinical samples analysis

    Article • Microchemical Journal, August 2022, Elsevier

    Dr Taher Entezari-Maleki

  16. New Variants of SARS‐CoV‐2 and Next Generation of COVID‐19 Treatments

    Article • The Journal of Clinical Pharmacology, May 2022, Wiley

    Dr Taher Entezari-Maleki

  17. The role of antigen-presenting cells in the pathogenesis of COVID-19

    Article • Pathology - Research and Practice, May 2022, Elsevier

    Dr Taher Entezari-Maleki

  18. Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists

    Article • Molecular Psychiatry, April 2022, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  19. SARS-CoV-2 and probable lung cancer risk

    Article • Bioimpacts, March 2022, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  20. The impact of metformin on cardiac troponin-I and ST resolution in patients with ST elevation myocardial infarction undergoing thrombolytic therapy

    Article • Pharmaceutical Sciences, March 2022, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  21. Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic

    Article • Future Microbiology, March 2022, Future Medicine

    Dr Taher Entezari-Maleki

  22. Hypertensive Crisis Following COVID‐19 Vaccination

    Article • The Journal of Clinical Pharmacology, February 2022, Wiley

    Dr Taher Entezari-Maleki

  23. Investigational antiviral drugs for the treatment of COVID-19 patients

    Article • Archives of Virology, February 2022, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  24. Tocilizumab in COVID-19 management: addressing time of starting treatment

    Article • European Journal of Hospital Pharmacy, January 2022, BMJ

    Dr Taher Entezari-Maleki

  25. Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review

    Article • European Journal of Pharmacology, December 2021, Elsevier

    Dr Taher Entezari-Maleki

  26. Colchicine for the Prevention of Myocardial Injury Following Elective PCI: A Randomized Clinical Trial

    Article • Pharmaceutical Sciences, November 2021, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  27. Evaluation of the activated partial thromboplastin time and its influential factors in ischemic heart disease patients under heparin treatment

    Article • Blood Coagulation & Fibrinolysis, September 2021, Wolters Kluwer Health

    Dr Taher Entezari-Maleki

  28. Potential Roles of Vitamins in the Management of COVID-19: A Comprehensive Review

    Article • Pharmaceutical Sciences, July 2021, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  29. Therapeutic Application of Corticosteroids in COVID‐19: A Focus on Optimum Dose and Duration of Therapy

    Article • The Journal of Clinical Pharmacology, July 2021, Wiley

    Dr Taher Entezari-Maleki

  30. Preventive use of Calcitriol versus cholecalciferol on biochemical markers of Metabolic Bone Disease (MBD) in very low birth weight infants: a pilot randomized clinical trial

    Article • Pharmaceutical Sciences, June 2021, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  31. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis

    Article • European Journal of Pharmacology, April 2021, Elsevier

    Dr Taher Entezari-Maleki

  32. SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis

    Article • Life Sciences, April 2021, Elsevier

    Dr Taher Entezari-Maleki

  33. The effects of Allopurinol on levels of cardiac troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial

    Article • Pharmaceutical Sciences, March 2021, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  34. Pharmacist-Directed Self-Management of Blood Pressure Versus Conventional Management in Patients with Hypertension: A Randomized Control Trial

    Article • High Blood Pressure & Cardiovascular Prevention, March 2021, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  35. Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review

    Article • The Journal of Clinical Pharmacology, March 2021, Wiley

    Dr Taher Entezari-Maleki

  36. Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview

    Article • Pharmacology Research & Perspectives, January 2021, Wiley

    Dr Taher Entezari-Maleki

  37. A comprehensive review on sarilumab in COVID-19

    Article • Expert Opinion on Biological Therapy, November 2020, Taylor & Francis

    Dr Taher Entezari-Maleki

  38. The Impact of Clinical Pharmacist Interventions on Medication Errors Management in the Postoperative Cardiac Intensive Care Unit

    Article • Pharmaceutical Sciences, October 2020, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  39. The Randomized Clinical Trial of Pentoxifylline for Reduction of Blood Pressure in Patients with Primary Hypertension

    Article • Pharmaceutical Sciences, September 2020, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  40. A Comprehensive Review of Tocilizumab in COVID‐19 Acute Respiratory Distress Syndrome

    Article • The Journal of Clinical Pharmacology, July 2020, Wiley

    Dr Taher Entezari-Maleki

  41. Anticoagulation in COVID-19: DDI Perspective

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2020, SAGE Publications

    Dr Taher Entezari-Maleki

  42. Clopidogrel Adherence to AHA/ACC Guideline in Patients with Open Heart Surgery in a Tertiary Heart Center

    Article • Pharmaceutical Sciences, September 2019, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  43. Effects of Adding Pentoxifylline to Captopril on Primary Hypertension: A Pilot Randomized Clinical Trial

    Article • The Journal of Clinical Pharmacology, September 2019, Wiley

    Dr Taher Entezari-Maleki

  44. Curcumin for the prevention of myocardial injury following elective percutaneous coronary intervention; a pilot randomized clinical trial

    Article • European Journal of Pharmacology, September 2019, Elsevier

    Dr Taher Entezari-Maleki

  45. Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial

    Article • International Urology and Nephrology, March 2019, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  46. Detection and Management of Common Medication Errors inInternal Medicine Wards: Impact on Medication Costs and Patient Care

    Article • Advanced Pharmaceutical Bulletin, February 2019, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  47. Isotretinoin; A review on the Utilization Pattern in Pregnancy

    Article • Advanced Pharmaceutical Bulletin, August 2018, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  48. Procalcitonin May Not Discriminate Between Sepsis and Non-Infective Systemic Inflammatory Response Syndrome (SIRS) in Heterogonous Critically Ill Patients

    Article • Archives of Clinical Infectious Diseases, January 2018, Kowsar Medical Institute

    Dr Taher Entezari-Maleki

  49. Effect of Vitamin D in the Prevention of Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial

    Article • The Journal of Clinical Pharmacology, August 2017, Wiley

    Dr Taher Entezari-Maleki

  50. Effect of Pentoxifylline in Ameliorating Myocardial Injury in Patients With Myocardial Infarction Undergoing Thrombolytic Therapy: A Pilot Randomized Clinical Trial

    Article • The Journal of Clinical Pharmacology, May 2017, Wiley

    Dr Taher Entezari-Maleki

  51. Measurement and Comparison of Inpatient Antibiotic Use in Five Different Hospitals in Tabriz

    Article • Pharmaceutical Sciences, March 2017, MaadRayan Publishing Company

    Dr Taher Entezari-Maleki

  52. Antimicrobial susceptibility patterns among bacteria isolated from intensive care units of the largest teaching hospital at the northwest of Iran

    Article • Brazilian Journal of Pharmaceutical Sciences, September 2016, FapUNIFESP (SciELO)

    Dr Taher Entezari-Maleki

  53. The randomized clinical trial of coenzyme Q10 for the prevention of periprocedural myocardial injury following elective percutaneous coronary intervention

    Article • Cardiovascular Therapeutics, July 2016, Wiley

    Dr Taher Entezari-Maleki

  54. The Effect of Treatment of Vitamin D Deficiency on the Level of P-Selectin and hs-CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial

    Article • The Journal of Clinical Pharmacology, June 2016, Wiley

    Dr Taher Entezari-Maleki

  55. A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis

    Article • Journal of Research in Pharmacy Practice, January 2016, Medknow

    Dr Taher Entezari-Maleki

  56. anticoagulation management services

    Article • The Journal of Clinical Pharmacology, September 2015, Wiley

    Dr Taher Entezari-Maleki

  57. The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2015, SAGE Publications

    Dr Taher Entezari-Maleki

  58. The pattern and risk factors associated with adverse drug reactions induced by Reteplase in patients with acute ST-elevation myocardial infarction: The first report from Iranian population

    Article • Journal of Research in Pharmacy Practice, January 2015, Medknow

    Dr Taher Entezari-Maleki

  59. A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention

    Article • European Journal of Clinical Pharmacology, December 2014, Springer Science + Business Media

    Dr Taher Entezari-Maleki

  60. A two-year utilization of the pharmacist-operated drug information center in Iran

    Article • Journal of Research in Pharmacy Practice, January 2014, Medknow

    Dr Taher Entezari-Maleki

  61. A review on comparing two commonly used rabbit anti-thymocyte globulins as induction therapy in solid organ transplantation

    Article • Expert Opinion on Biological Therapy, July 2013, Taylor & Francis

    Dr Taher Entezari-Maleki

  62. The evaluation of isotretinoin induced adverse drug reactions

    Article • African Journal of Pharmacy and Pharmacology, October 2011, Academic Journals

    Dr Taher Entezari-Maleki